Data / Drug companies / Cohance Lifesciences Limited
Cohance Lifesciences Limited: 24 products in the FDA NDC directory, labeler code 17511
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Cohance Lifesciences Limited (labeler code 17511) lists 24 products in the FDA National Drug Code Directory. By type: 24 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on February 14, 2022.
The request: Watch Cohance Lifesciences Limited (FDA labeler code 17511): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 17511
- Products in commercial distribution
- 24
- Packages
- 24
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 2
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- August 30, 2006
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients for compounding | 14 | 58.3% |
| Bulk ingredients | 10 | 41.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 24 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 21 | 87.5% |
| Tablet | 3 | 12.5% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Lamotrigine | 17511-103 | Powder | Bulk ingredients | February 14, 2022 |
| Mexiletine hydrochloride | 17511-136 | Powder | Bulk ingredients | June 21, 2021 |
| Tk112690 | 17511-135 | Powder | Bulk ingredients | January 5, 2021 |
| Posaconazole | 17511-133 | Powder | Bulk ingredients for compounding | December 8, 2020 |
| Midazolam hydrochloride | 17511-134 | Powder | Bulk ingredients | November 28, 2020 |
| Verapamil hydrochloride | 17511-132 | Powder | Bulk ingredients for compounding | July 14, 2020 |
| Hydralazine hydrochloride | 17511-102 | Powder | Bulk ingredients for compounding | July 14, 2020 |
| Meclizine hydrochloride | 17511-108 | Powder | Bulk ingredients | February 10, 2020 |
| Dipyridamole | 17511-122 | Powder | Bulk ingredients for compounding | January 20, 2020 |
| Tolcapone | 17511-119 | Powder | Bulk ingredients for compounding | January 20, 2020 |
| Tamsulosin hydrochloride | 17511-118 | Powder | Bulk ingredients | January 20, 2020 |
| Itraconazole | 17511-114 | Powder | Bulk ingredients | January 20, 2020 |
| Levocetirizine dihydrochloride | 17511-106 | Powder | Bulk ingredients | January 20, 2020 |
| Flurbiprofen | 17511-123 | Powder | Bulk ingredients for compounding | January 17, 2020 |
| Midazolam | 17511-115 | Powder | Bulk ingredients | January 17, 2020 |
| Ferric citrate | 17511-124 | Powder | Bulk ingredients for compounding | October 11, 2018 |
| Baclofen | 17511-130 | Tablet | Bulk ingredients for compounding | October 10, 2018 |
| Diflunisal | 17511-129 | Tablet | Bulk ingredients for compounding | October 10, 2018 |
| Propiomazine maleate | 17511-128 | Tablet | Bulk ingredients for compounding | October 10, 2018 |
| Zonisamide | 17511-137 | Powder | Bulk ingredients | October 9, 2018 |
| Entacapone | 17511-109 | Powder | Bulk ingredients for compounding | July 30, 2010 |
| Doxazosin mesylate | 17511-113 | Powder | Bulk ingredients for compounding | July 31, 2009 |
| Metaxalone | 17511-104 | Powder | Bulk ingredients for compounding | November 30, 2007 |
| Fomepizole | 17511-101 | Powder | Bulk ingredients for compounding | August 30, 2006 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.